Madam Speaker, I heard a lot of points in the member's speech, especially around beef. There are still some non-tariff issues that exist in CETA. There still are some concerns by cattlemen on being able to get that product in. It is often non-tariff that actually prevents them from seeing the benefits of that tariff reduction. There are still some issues that need to be fixed around beef and exports, and that comes straight from their presentation to us at the committee level.
My question for the member is something about which he did not speak, and that is the cost of drugs for Canadians. Twenty-five per cent of the agreement speaks to patent changes that will impact every Canadian, all Canadians who are already experiencing the high cost of drugs. I have people in my riding every day in my office. They are struggling to pay the costs of medication. Affordable medication in our country is a serious issue, and I would hope it would be a serious issue for the member as well.
Could the member speak to how it will impact his riding to have seniors and people who will struggle with the cost of medication because of the changes in CETA?